SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced the appointment of Brian Farley to the company’s board of directors, effective March 9, 2012.
Farley has more than 30 years of experience in the medical device arena. He presently serves as president and chief executive officer (CEO) of Entellus Medical and serves as Chairman of the Board for Neuronetics Inc., a private medical company focused on the non-invasive treatment of drug-resistant depression. He is also a member of the advisory board for the Purdue University Biomedical Engineering Department.
Before joining Entellus, Farley spent more than a decade as president and CEO of VNUS Medical Technologies, where he led the company through a successful initial public offering prior to its eventual sale to Covidien in 2009. Prior to VNUS, Farley held various management and executive positions at DVI, Guidant Corporation and Eli Lilly and Company.
“We conducted an extensive search, and Brian stood out as an exceptional candidate based on his in-depth knowledge of the medical devices field, and his solid operational and technological experience, which we found to be particularly relevant to our business,” said Kevin Mosher, CEO of DFINE. “He will be a valuable addition to our organization, as we continue to develop and demonstrate the clinical acceptance of our minimally invasive treatments for vertebral pathologies in the marketplace."
About DFINE, Inc.
DFINE is dedicated to relieving pain and improving the quality of life for patients suffering from vertebral pathologies through innovative, minimally invasive therapies. The company’s devices are built on an extensible radiofrequency platform that currently covers two procedural applications: the treatment of vertebral compression fractures (VCFs) with the StabiliT® Vertebral Augmentation System, and the palliative treatment of metastatic vertebral body lesions with the STAR™ Tumor Ablation System. Both systems represent generational advancements in the minimally invasive treatment of vertebral pathologies. DFINE is based in San Jose, Calif. and is a privately held company. For more information visit http://www.dfineinc.com.